Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: DexCom, Inc.

Market Cap 27.96B 24.37B 22.46B 21.13B 39.52B 2,636B 39.8B 267B 104B 1,299B 105B 103B 4,502B P/E 2026 *
29.6x
P/E 2027 * 24.8x
Enterprise Value 27.59B 24.04B 22.16B 20.85B 39B 2,601B 39.28B 264B 102B 1,282B 104B 101B 4,442B EV / Sales 2026 *
5.28x
EV / Sales 2027 * 4.58x
Free-Float
93.34%
Yield 2026 *
-
Yield 2027 * -
1 week-2.76%
Current month+0.62%
1 month+13.27%
3 months+7.62%
6 months+12.81%
Current year+10.88%
1 week 62.01
Extreme 62.01
65.53
1 month 55.6
Extreme 55.6
68.1
3 years 46.85
Extreme 46.85
132
5 years 46.85
Extreme 46.85
144.8
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-2.76%-10.26%-46.67% 27.96B
-0.10%-1.38%-33.23%-16.75% 154B
+1.54%-1.23%-7.45%-11.00% 102B
-4.45%+3.12%+59.84%+56.09% 59.25B
-1.90%-3.43%-8.40%+48.53% 52.89B
+1.67%-2.29%-14.60%-44.33% 39.67B
-1.32%-3.20% - - 30.39B
-1.25%-0.72%+50.47%-9.42% 23.17B
-1.53%+1.14%-15.03%-5.42% 20.7B
-1.33%-7.06%-19.37%-32.31% 18.48B
Average -0.68%-0.84%+0.22%-6.81% 55.6B
Weighted average by Cap. -0.44%-0.24%-6.31%-3.62%

Financials

2026 *2027 *
Net sales 5.22B 4.55B 4.2B 3.95B 7.38B 492B 7.44B 49.93B 19.39B 243B 19.61B 19.19B 841B 5.83B 5.08B 4.68B 4.4B 8.24B 549B 8.3B 55.71B 21.63B 271B 21.88B 21.41B 938B
Net income 963M 839M 773M 727M 1.36B 90.72B 1.37B 9.2B 3.57B 44.71B 3.61B 3.54B 155B 1.16B 1.01B 930M 875M 1.64B 109B 1.65B 11.06B 4.3B 53.77B 4.35B 4.25B 186B
Net Debt -370M -322M -297M -279M -522M -34.82B -526M -3.53B -1.37B -17.16B -1.39B -1.36B -59.48B -1.25B -1.09B -1B -943M -1.76B -118B -1.78B -11.92B -4.63B -57.94B -4.68B -4.58B -201B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
-
Date Price Change
20/06/26 63.40 0.00%
18/06/26 63.40 +2.16%
17/06/26 62.06 -1.82%
16/06/26 63.21 -1.54%
15/06/26 64.20 -1.29%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
72.47USD
Average target price
85.21USD
Spread / Average Target
+17.58%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!